GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » ROE % Adjusted to Book Value

4basebio (LSE:4BB) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio ROE % Adjusted to Book Value?

4basebio's ROE % for the quarter that ended in Jun. 2024 was 0.00%. 4basebio's PB Ratio for the quarter that ended in Jun. 2024 was N/A. 4basebio's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was N/A.

4basebio ROE % Adjusted to Book Value Historical Data

The historical data trend for 4basebio's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio ROE % Adjusted to Book Value Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - -3.68 -4.46 -

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.31 -5.33 -6.50 - -

Competitive Comparison of 4basebio's ROE % Adjusted to Book Value

For the Biotechnology subindustry, 4basebio's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4basebio's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 4basebio's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where 4basebio's ROE % Adjusted to Book Value falls into.


;
;

4basebio ROE % Adjusted to Book Value Calculation

4basebio's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-231.29% / N/A
=N/A

4basebio's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4basebio ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of 4basebio's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (LSE:4BB) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
LSE:BVXP LSE:FARN LSE:AVCT LSE:HVO LSE:SCLP LSE:IBT LSE:OBI LSE:SBTX LSE:FUM LSE:TRX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
88Q:Germany
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
Website
https://www.4basebio.com
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio Headlines

No Headlines